ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Maningas Cosmetic Surgery Introduces Weight Loss Injections with Semaglutide & Tirzepatide to Joplin Practice

Joplin, MO—Talon Maningas, DO, and the aesthetics team at Maningas Cosmetic Surgery, are excited to announce the addition of Semaglutide and Tirzepatide weight loss injections in Joplin to their comprehensive suite of wellness and aesthetic services. These new options offer a modern approach to achieving sustainable weight loss and are proving transformative for those who have struggled with weight management; treatment is now available at the Joplin clinic.

“We are pleased to expand our offerings with Semaglutide and Tirzepatide injections,” says triple-board certified Joplin cosmetic surgeon Dr. Talon Maningas. “These treatments are proven to promote significant weight loss and contribute to overall health improvements, aligning perfectly with our holistic approach to patient care.”

Semaglutide was originally developed to treat type 2 diabetes and has shown remarkable efficacy in promoting significant weight loss for suitable patients. This medication works by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which targets areas of the brain that regulate appetite and food intake and has been approved by the FDA as a medical weight loss treatment. Clinical trials demonstrate that patients using Semaglutide experience significant weight loss, making it a highly effective option for individuals who have struggled to achieve their weight loss goals through diet and exercise alone.

Tirzepatide, another FDA-approved injectable weight loss medication, combines the effects of two hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). This dual-action approach regulates appetite and also enhances the body’s natural ability to manage blood sugar levels. Patients receiving Tirzepatide have reported substantial weight loss and improved metabolic health. Targeting multiple pathways involved in weight regulation makes Tirzepatide another promising solution for medical weight loss.

“The safety and efficacy of medical weight loss relies on developing a treatment plan that will suit both the patient’s physiology and lifestyle. We offer multiple weight loss medication options to provide more personalized treatment, tuned to each patient’s unique needs,” says Dr. Maningas.

At Maningas Cosmetic Surgery, patients seeking weight loss injections in Joplin first meet with Dr. Maningas’ nursing staff to review their medical history, lifestyle, and expectations to ensure they are good candidates for the treatment. Eligible patients generally include those who have a BMI over 30 or those with a BMI of 27 or greater who also have weight-related medical issues, such as high blood pressure, high cholesterol, or type 2 diabetes.

Those who move forward with the 12-week program are monitored monthly, or as needed, by their provider to track their progress and make adjustments to their weight loss plan when desired for maximum effects. Patients have the option of administering the self-injections at home or a nurse can administer the weekly injection at the Joplin cosmetic surgery practice. The program duration can be extended beyond 12 weeks for patients who wish to experience greater weight loss.

Aside from losing weight, Semaglutide and Tirzepatide injections may also offer additional health benefits. Research shows that these medications can improve markers of cardiovascular health, reduce the risk of diabetes, and help patients become more aware of their food intake and eating habits. Another advantage of these weight loss medications is how they can help the body gently adjust to and be satisfied with smaller, healthier portions. Many patients easily maintain their weight goals because they continue eating the healthier foods and portion sizes they transitioned to while taking weight loss injections.

“We’ve designed our weight management program to help our patients achieve their weight loss goals and keep the weight off,” says Nurse Andrea, the weight loss program director. “Each patient in the program receives individualized coaching throughout their treatment so they have the tools and confidence to take care of their bodies and manage their weight long after their treatments have ended.”

In addition to weight loss injections, the practice offers hormone replacement therapy (HRT) for women and men, which is another beneficial treatment that can play a vital role in supporting weight loss efforts. Patients work with Nurse Andrea to design a fully customized functional wellness treatment plan using either or both of these treatments.

To learn more about weight loss injections with Semaglutide or Tirzepatide, please visit the Maningas Cosmetic Surgery website or call (417) 437-0303.

###

For more information about Maningas Cosmetic Surgery, contact the company here:

Maningas Cosmetic Surgery
Dallas Peternell
417-437-0303
dallas@mcosmeticsurgery.com
620 W 32nd St B, Joplin, MO 64804

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.